MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 12.11.2025
Land |
 Vereinigte Staaten |
IPO-Jahr |
2020 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
5.01 M |
Marktkapitalisierung |
$ 49.1 M |
EBITDA (LTM) |
$ -173 M |
P/E (LTM) |
- |
P/S (LTM) |
148.89 |
EPS (LTM) |
-31.93 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market |  Germany |
 |
Annovis Bio
ANVS
|
$ 2.52 | 1.2 % | $ 22.7 M | NYSE American | USA |
 |
Acorda Therapeutics
ACOR
|
- | -24.86 % | $ 820 K | Nasdaq Global Select Market | USA |
 |
Alterity Therapeutics Limited
ATHE
|
$ 3.56 | 3.79 % | $ 8.57 B | Nasdaq Capital Market |  Australia |
 |
Actinium Pharmaceuticals
ATNM
|
$ 1.21 | 0.74 % | $ 36.4 M | NYSE American | USA |
 |
Autolus Therapeutics plc
AUTL
|
$ 1.62 | 7.28 % | $ 413 M | Nasdaq Global Select Market |  Britain |
 |
Axsome Therapeutics
AXSM
|
$ 162.88 | 0.34 % | $ 8.1 B | Nasdaq Global Market,SPB | USA |
 |
Aytu BioScience
AYTU
|
$ 2.58 | 2.38 % | $ 16.2 M | Nasdaq Capital Market | USA |
 |
I-Mab
IMAB
|
- | - | $ 866 M | Nasdaq Global Select Market |  China |
 |
BridgeBio Pharma
BBIO
|
$ 64.71 | -0.99 % | $ 12.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Bicycle Therapeutics plc
BCYC
|
$ 5.32 | 2.31 % | $ 310 M | Nasdaq Global Select Market | Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | USA |
 |
Atara Biotherapeutics
ATRA
|
$ 7.11 | 37.52 % | $ 53.2 M | Nasdaq Global Select Market,SPB | USA |
 |
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market |  France |
 |
Beam Therapeutics
BEAM
|
$ 26.95 | 1.53 % | $ 2.67 B | Nasdaq Global Select Market | USA |
 |
Aeglea BioTherapeutics
AGLE
|
- | - | $ 1.01 B | Nasdaq Global Market | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$ 9.66 | -2.62 % | $ 625 M | NYSE | USA |
 |
Biogen
BIIB
|
$ 184.68 | -0.1 % | $ 27.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market | Britain |
 |
BioVie
BIVI
|
$ 1.34 | -1.47 % | $ 1.98 M | Nasdaq Capital Market | USA |
 |
Alpine Immune Sciences
ALPN
|
- | - | $ 2.17 B | Nasdaq Global Market | USA |
 |
BioLineRx Ltd.
BLRX
|
$ 2.65 | - | $ 908 M | Nasdaq Capital Market |  Israel |
 |
BioMarin Pharmaceutical
BMRN
|
$ 60.17 | -1.55 % | $ 11.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Bristol-Myers Squibb Company
BMY
|
$ 60.1 | -0.32 % | $ 122 B | NYSE,SPB | USA |
 |
Benitec Biopharma
BNTC
|
$ 12.76 | 12.52 % | $ 525 M | Nasdaq Capital Market | USA |
 |
BioNTech SE
BNTX
|
$ 100.99 | -0.51 % | $ 27.2 B | Nasdaq Global Select Market | Germany |
 |
Adverum Biotechnologies
ADVM
|
- | - | $ 86.2 M | Nasdaq Global Market | USA |
 |
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX |  Russia |
 |
ADC Therapeutics SA
ADCT
|
$ 4.07 | -0.73 % | $ 105 M | NYSE |  Schweiz |
 |
Acer Therapeutics
ACER
|
- | 2.71 % | $ 14 M | Nasdaq Capital Market | USA |
 |
ARCA biopharma
ABIO
|
- | 1052.0 % | $ 415 M | Nasdaq Capital Market | USA |
 |
BioXcel Therapeutics
BTAI
|
$ 1.72 | 16.22 % | $ 4.36 M | Nasdaq Global Select Market,SPB | USA |
 |
Burford Capital Limited
BUR
|
$ 8.05 | 3.67 % | $ 1.31 B | NYSE | Britain |
 |
Aeterna Zentaris
AEZS
|
- | 5.93 % | $ 314 M | Nasdaq Capital Market |  Canada |
 |
AgeX Therapeutics
AGE
|
- | -10.17 % | $ 12.2 K | NYSE American | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
- | - | $ 26.5 M | Nasdaq Global Select Market | USA |
 |
BeyondSpring
BYSI
|
$ 1.45 | - | $ 58.5 M | Nasdaq Capital Market | USA |
 |
Cabaletta Bio
CABA
|
$ 3.18 | 0.42 % | $ 3.71 M | Nasdaq Global Select Market | USA |
 |
Akero Therapeutics
AKRO
|
- | - | $ 3.67 B | Nasdaq Global Select Market,SPB | USA |
 |
Akouos
AKUS
|
- | 0.23 % | $ 488 M | Nasdaq Global Select Market | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
$ 3.93 | -13.63 % | $ 8.55 B | NYSE American | Israel |
 |
Capricor Therapeutics
CAPR
|
$ 29.47 | 5.61 % | $ 789 M | Nasdaq Capital Market | USA |
 |
Acasti Pharma
ACST
|
- | 4.01 % | $ 150 M | Nasdaq Capital Market | Canada |
 |
Catalyst Biosciences
CBIO
|
$ 11.83 | -2.03 % | $ 779 M | Nasdaq Capital Market | USA |
 |
Ampio Pharmaceuticals
AMPE
|
- | -11.43 % | $ 502 K | NYSE American | USA |
 |
C4 Therapeutics
CCCC
|
$ 3.62 | 18.91 % | $ 300 M | Nasdaq Global Select Market | USA |
 |
Codexis
CDXS
|
$ 1.23 | -0.41 % | $ 90.3 M | Nasdaq Global Select Market | USA |
 |
Cerus Corporation
CERS
|
$ 1.86 | -3.89 % | $ 355 M | Nasdaq Global Market | USA |